FAMILIAL HETEROZYGOUS HYPERCHOLESTEROLEMIA: A CASE REPORT
Author(s) -
Вячеслав Миколайович Ждан,
Ye. M. Kіtura,
М. Yu. Babanina,
O. Ye. Kitura,
М. В. Ткаченко
Publication year - 2019
Publication title -
wiadomości lekarskie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.133
H-Index - 14
eISSN - 2719-342X
pISSN - 0043-5147
DOI - 10.36740/wlek201905140
Subject(s) - familial hypercholesterolemia , medicine , disease , heterozygote advantage , compound heterozygosity , coronary heart disease , genetic disorder , hereditary diseases , pediatrics , bioinformatics , cholesterol , genetics , gene , mutation , allele , biology
OBJECTIVEІntroduction: Familial hypercholesterolemia (FH) is an autosomal dominant disorder, caused by the defect of the gene, encoding the structure and function of the receptor for the apoprotein B/E. Patients with FH are predisposed to premature development of atherosclerosis and clinically manifested forms of cardiovascular diseases, in particular coronary heart disease (CHD). The aim of our article is informing the general practitioners about the diagnosis and management of patients with familial heterozygous hypercholesterolemia.PATIENTS AND METHODSMaterials and methods: The data of domestic and foreign literature were analyzed. The case report of familial heterozygous hypercholesterolemia (FHH) was present in this article. Diagnostic criteria, current approaches to the management of patients with hereditary disorders of lipid metabolism are considered.CONCLUSIONConclusions: Familial heterozygous hypercholesterolemia is one of the most common genetic disorders, but this pathology is not well-known to practitioners and is often underdiagnosed. Early diagnosis and aggressive contemporary hypolipidemic therapy is crucial for patients with signs of hereditary lipid disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom